Mycronic AB: Mycronic Adjusts the Outlookupwards for Full Year Sales in 2016

Regulatory News:

Mycronic (STO:MYCR)

Mycronic AB (publ), today adjusts the outlook upwards for full year sales in 2016 to the level of SEK 2,200 million, excluding effects from acquisitions.

The background for the upward adjustment is a combination of earlier delivery of a Prexision-80 mask writer, an order received in December 2015, the change in product mix within Mycronic’s both business areas as well as currency effects. The current assessment for sales in 2016 has been at the level of SEK 1,900 million, excluding effects from acquisitions. Mycronic’s mask writer Prexision-80 is an advanced system for cost-effective manufacturing of the most advanced photomasks for display applications. At the time of the order it was agreed with the customer that delivery would take place during first quarter of 2017 at the latest. A successful completion of the project and agreement with the customer has enabled delivery in December 2016.

About Mycronic AB

Mycronic AB is a Swedish high-tech company engaged in the development, manufacture and marketing of production equipment with high precision and flexibility requirements for the electronics industry. Mycronic headquarters are located in Täby, north of Stockholm and the Group has subsidiaries in China, France, Germany, Japan, Singapore, South Korea, the Netherlands, United Kingdom and the United States. For more information see our web site at: www.mycronic.com

Mycronic AB (publ) is listed on NASDAQ Stockholm, Mid Cap: MYCR.

The information is of the type that Mycronic is required to disclose in accordance with the EU Market Abuse Regulation. The information was submitted for publication, through the contact persons stated above, on 6 December, 2016, at 8.00 am.

This information was brought to you by Cision http://news.cision.com

View source version on businesswire.com: http://www.businesswire.com/news/home/20161205006418/en/